Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: Analysis of efficacy and toxicity

Seok Jin Kim, Kihyun Kim, Yong Park, Byung Soo Kim, Jooryung Huh, Young Hae Ko, Keunchil Park, Cheolwon Suh, Won Seog Kim

Research output: Contribution to journalArticle

17 Citations (Scopus)

Fingerprint Dive into the research topics of 'Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: Analysis of efficacy and toxicity'. Together they form a unique fingerprint.

Medicine & Life Sciences